Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 2500.00 | 1955.17 | 4562.00 | 4404.75 | 1.0357 | 1.0608 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4494.00 | 4404.75 | 1.0203 | 1.0345 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 2500.00 | 1955.17 | 4513.00 | 4404.75 | 1.0246 | 1.0419 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 2500.00 | 1955.17 | 2225.00 | 4404.75 | 0.5051 | 0.1167 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 2500.00 | 1955.17 | 4291.00 | 4404.75 | 0.9742 | 0.9558 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 2500.00 | 1955.17 | 2258.00 | 4404.75 | 0.5126 | 0.1308 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4468.00 | 4404.75 | 1.0144 | 1.0245 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4327.00 | 4404.75 | 0.9824 | 0.9698 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 2500.00 | 1955.17 | 4445.00 | 4404.75 | 1.0091 | 1.0156 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4438.00 | 4404.75 | 1.0075 | 1.0129 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4042.00 | 4404.75 | 0.9177 | 0.8586 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4045.00 | 4404.75 | 0.9183 | 0.8597 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4125.00 | 4404.75 | 0.9365 | 0.8911 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 2500.00 | 1955.17 | 4384.00 | 4404.75 | 0.9953 | 0.9920 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 2500.00 | 1955.17 | 3640.00 | 4404.75 | 0.8264 | 0.6996 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 1799.00 | 4404.75 | 0.4084 | -0.0686 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 2500.00 | 1955.17 | 2870.00 | 4404.75 | 0.6516 | 0.3876 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 2500.00 | 1955.17 | 4460.00 | 4404.75 | 1.0125 | 1.0214 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 4373.00 | 4404.75 | 0.9928 | 0.9877 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 2500.00 | 1955.17 | 3621.00 | 4404.75 | 0.8221 | 0.6920 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 2240.00 | 4404.75 | 0.5085 | 0.1231 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 2500.00 | 1955.17 | 2507.00 | 4404.75 | 0.5692 | 0.2364 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 4314.00 | 4404.75 | 0.9794 | 0.9648 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 4197.00 | 4404.75 | 0.9528 | 0.9192 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 2500.00 | 1955.17 | 4304.00 | 4404.75 | 0.9771 | 0.9609 |